Cargando…
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors
INTRODUCTION: Ankylosing spondylitis (AS) is unique in its pathology where inflammation commences at the entheses before progressing to an osteoproliferative phenotype generating excessive bone formation that can result in joint fusion. The underlying mechanisms of this progression are poorly unders...
Autores principales: | Haynes, Katelin R, Pettit, Allison R, Duan, Ran, Tseng, Hsu-Wen, Glant, Tibor T, Brown, Matthew A, Thomas, Gethin P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674607/ https://www.ncbi.nlm.nih.gov/pubmed/23171658 http://dx.doi.org/10.1186/ar4096 |
Ejemplares similares
-
Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression
por: Haynes, Katelin R., et al.
Publicado: (2015) -
Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis
por: Tseng, Hsu-Wen, et al.
Publicado: (2017) -
Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes
por: Tseng, Hsu-Wen, et al.
Publicado: (2016) -
Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis
por: Fischer, Roman, et al.
Publicado: (2012) -
Ankylosing spondylitis
Publicado: (1980)